CD29和EGFR在乳腺癌中的表达及临床意义  

Expression and Clinical Significance of CD29 and EGFR in Breast Cancer

在线阅读下载全文

作  者:邱立[1] 柳玉红[1] 龚静青[1] 汪春福[1] 

机构地区:[1]广东省深圳市宝安区人民医院,广东深圳518101

出  处:《中国医学创新》2017年第12期51-54,共4页Medical Innovation of China

基  金:宝安区科技计划项目(2012015)

摘  要:目的:探讨粘附因子CD29和表皮生长因子受体(EGFR)在乳腺癌中的表达情况和临床意义。方法:收集乳腺癌标本98例,腺病52例。利用免疫组织化学方法检测CD29与EGFR的阳性表达率,并分析两者的相关性。结果:CD29和EGFR在腺病中的阳性表达率分别为5.8%(3/52)和3.8%(2/52),在乳腺癌中的阳性表达率分别为70.4%(69/98)和62.2%(61/98),在同一病种两者的阳性表达率比较,差异均无统计学意义(P>0.05),但两者在乳腺癌中的阳性表达率均明显高于腺病,差异均有统计学意义(P<0.05)。浸润性癌阳性表达率均高于原位癌(P<0.05),高级别癌的阳性表达率均高于低级别癌(P<0.05),有淋巴结转移的阳性表达率均高于无转移(P<0.05)。结论:CD29和EGFR的高表达与乳腺癌的发生、分化及转移有相关性,而且两者表达均呈正相关,因此检测乳腺癌的CD29和EGFR对治疗及预后有指导作用。Objective: To investigate the expression and clinical significance of CD29 and epidermal growth factor receptor ( EGFR ) in breast cancer.Method: Collected 98 cases of breast cancer specimens, 52 cases of adenomy0sis.The positive expression rates of CD29 and EGFR were detected by immunohistochemistry, and the correlation between them was analyzed.Result: The positive expression of CD29 and EGFR in adenosis rates were 5.8% ( 3/52 ) and 3.8% ( 2/52 ), the positive expression rate in breast cancer were 70.4% ( 69/98 ) and 62.2% ( 61/98 ), there were no significant differences in the positive expression rate of the same disease ( P〉0.05 ), but the positive expression both in breast cancer rates were significantly higher than those of adenosis, the differences were statistically significant ( P〈0.05 ) .The positive expression rate of invasive carcinoma was higher than that in situ carcinoma ( P〈0.05 ), and the positive expression rate of advanced carcinoma was higher than that of low grade carcinoma ( P〈0.05 ), the positive expression rate Of lymph node metastasis was higher than that of non metastasis ( P〈0.05 ) .Conclusion: The high expression of CD29 and EGFR are correlated with the occurrence, differentiation and metastasis of breast cancer, and there is a positive correlation between them, therefore, the detection of CD29 and breast cancer has a guiding effect on the treatment and prognosis.

关 键 词:乳腺癌 粘附因子CD29 表皮生长因子受体 

分 类 号:R737.9[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象